ASSERTIO HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 USD | 0.00% |
|
+14.29% | +12.15% |
| 30/05 | Declaration of Voting Results by Assertio Holdings | CI |
| 30/05 | Declaration of Voting Results by Assertio Holdings | CI |
Chart calendar Assertio Holdings, Inc.
6e25d1055878420.7qgcy3DpstNWboMi4MI0Mzha6DZPn6A-VLRSoFY6Rp4.j-N_vQXe3J4xC9wao5d3dkIY2XF26OtXNeQIzmVsE_eHmk2CKp7eujkftw~7fb98aefb0d12a70ac302fc7c0d28bb6
Upcoming events on Assertio Holdings, Inc.
Past events on Assertio Holdings, Inc.
| 12/06/2024 08:15 pm | Sidoti Small Cap Conference |
| 23/05/2024 11:00 pm | Annual General Meeting |
| 22/05/2024 01:10 am | Alliance Global Partners Healthcare Showcase |
| 13/05/2024 09:30 pm | Citizens JMP Life Sciences Conference |
| 07/05/2024 02:00 am | Q1 2024 Earnings Call |
| 07/05/2024 01:31 am | Q1 2024 Earnings Release |
| 10/04/2024 01:30 am | LD Micro Invitational Conference |
| 12/03/2024 02:00 am | Q4 2023 Earnings Call |
| 12/03/2024 01:31 am | Q4 2023 Earnings Release |
| 09/11/2023 03:00 am | Q3 2023 Earnings Call |
| 09/11/2023 02:31 am | Q3 2023 Earnings Release |
| 04/08/2023 02:00 am | Q2 2023 Earnings Call |
| 04/08/2023 01:34 am | Q2 2023 Earnings Release |
| 27/07/2023 | Extraordinary Shareholders Meeting - M&A Vote |
| 10/05/2023 11:00 pm | Annual General Meeting |
| 09/05/2023 09:00 pm | Q1 2023 Earnings Call |
| 09/05/2023 04:45 pm | Q1 2023 Earnings Release |
| 27/04/2023 04:30 am | Planet MicroCap Showcase |
| 25/04/2023 06:00 pm | Acquisition of Spectrum Pharmaceuticals Inc by Assertio Holdings, Inc Call |
| 23/03/2023 12:45 am | Sidoti Spring Small-Cap Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 230 227 1.06% | 106 106 0.28% | 111 108 2.36% | 156 153 1.9% | 152 153 -0.55% | 121 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 22,4 5,00 348.26% | 48,8 47,7 2.3% | 102 99,4 2.23% | 67,7 72,6 -6.64% | 25,6 |
|
EBIT Million USD | Released Forecast Spread | 137 129 6.21% | 20,8 12,7 63.84% | 19,8 39,4 -49.84% | 39,4 54,4 -27.58% | -244 -213 -14.57% | -17,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,55 0,92 -160.37% | 31,2 38,4 -18.82% | -254 -224 -13.27% | -17,3 |
|
Net income Million USD | Released Forecast Spread | -217 -42,7 -409.22% | -28,1 -9,01 -212.23% | -1,28 0,30 -532.77% | 110 69,3 58.26% | -332 -276 -20.09% | -15,7 |
|
EPS USD | Released Forecast Spread | -12,3 -2,40 -411.67% | -1,08 -0,36 -200% | -0,03 0,01 -400% | 2,03 0,91 121.92% | -4,67 -3,41 -36.95% | -0,16 |
| Announcement Date | 09/03/20 | 11/03/21 | 09/03/22 | 08/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 36,5 33,1 10.5% | 35,1 31,8 10.55% | 34,2 31,3 9.13% | 50,4 47,4 6.14% | 42,5 37,6 12.83% | 41,0 39,8 2.9% | 35,6 50,4 -29.35% | 33,0 33,8 -2.45% | 32,4 29,5 9.95% | 30,2 | 29,2 | 29,4 | 31,4 | 33,4 |
|
EBITDA Million USD | Released Forecast Spread | 23,9 17,4 37.4% | 22,9 16,4 39.28% | 21,4 15,7 36.98% | 33,4 30,4 9.63% | 25,6 22,0 16.6% | 24,8 23,0 7.68% | 12,9 18,9 -31.77% | 4,45 6,88 -35.35% | 7,38 5,72 29% | 6,77 | 6,34 | 5,12 | 6,96 | 7,29 |
|
EBIT Million USD | Released Forecast Spread | 11,6 16,3 -28.95% | 10,8 10,1 7.06% | 6,43 8,36 -23% | 10,6 15,9 -33.34% | 4,64 13,5 -65.67% | 12,4 14,9 -16.72% | 13,6 7,26 87.17% | -32,3 -1,37 -2267.56% | -4,34 -3,20 -35.4% | -3,51 | -4,81 | -4,99 | 4,08 | 6,99 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,78 6,02 62.46% | 8,43 5,65 49.23% | 4,38 4,55 -3.61% | 8,58 15,2 -43.71% | -5,59 10,2 -154.7% | 12,3 12,3 0.3% | -229 10,2 -2345.73% | -31,9 -2,12 -1407.8% | -4,38 -3,45 -26.79% | -3,47 | -4,43 | -5,00 | 0,32 | 1,93 |
|
Net income Million USD | Released Forecast Spread | 9,06 4,75 90.66% | 7,83 3,75 108.67% | 4,17 3,52 18.55% | 88,6 48,2 83.78% | -3,48 8,49 -141.01% | 8,47 10,2 -17.02% | -280 6,39 -4476.77% | -57,4 -1,87 -2961.3% | -4,51 -2,93 -54.06% | -3,03 | -3,80 | -4,39 | 0,24 | 1,77 |
|
EPS USD | Released Forecast Spread | 0,20 0,09 122.22% | 0,16 0,08 106.91% | 0,08 0,07 22.61% | 1,34 0,58 132.91% | -0,07 0,13 -153.54% | 0,13 0,14 -9.88% | -3,42 0,07 -4706.06% | -0,61 -0,02 -2950% | -0,05 -0,03 -66.67% | -0,03 | -0,04 | -0,04 | 0,00 | 0,02 |
| Announcement Date | 09/05/22 | 08/08/22 | 08/11/22 | 08/03/23 | 09/05/23 | 03/08/23 | 08/11/23 | 11/03/24 | 06/05/24 | - | - | - | - | - |
More events
Past sector events for Assertio Holdings, Inc.
| 21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
| 14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ASRT Stock
- Calendar Assertio Holdings, Inc.
